CN102091181A - Chinese medicinal composition for treating acute and chronic granulocytic leukemia 1 and preparation method thereof - Google Patents
Chinese medicinal composition for treating acute and chronic granulocytic leukemia 1 and preparation method thereof Download PDFInfo
- Publication number
- CN102091181A CN102091181A CN2011100426903A CN201110042690A CN102091181A CN 102091181 A CN102091181 A CN 102091181A CN 2011100426903 A CN2011100426903 A CN 2011100426903A CN 201110042690 A CN201110042690 A CN 201110042690A CN 102091181 A CN102091181 A CN 102091181A
- Authority
- CN
- China
- Prior art keywords
- grams
- radix
- chinese medicine
- medicine composition
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 14
- 230000001154 acute effect Effects 0.000 title claims abstract description 11
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 title abstract description 6
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 title abstract description 6
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 title abstract description 6
- 208000031261 Acute myeloid leukaemia Diseases 0.000 title abstract 3
- 239000003814 drug Substances 0.000 claims abstract description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229940079593 drug Drugs 0.000 claims abstract description 9
- 239000002775 capsule Substances 0.000 claims abstract description 5
- 235000008216 herbs Nutrition 0.000 claims abstract description 5
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 4
- 208000032839 leukemia Diseases 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 12
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims description 7
- 230000001684 chronic effect Effects 0.000 claims description 7
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 6
- 239000000796 flavoring agent Substances 0.000 claims description 6
- 235000019634 flavors Nutrition 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 5
- 230000003448 neutrophilic effect Effects 0.000 claims description 5
- 241000283690 Bos taurus Species 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 239000009636 Huang Qi Substances 0.000 claims description 3
- 239000010231 banlangen Substances 0.000 claims description 3
- 229940126678 chinese medicines Drugs 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 239000012634 fragment Substances 0.000 claims description 2
- 235000008434 ginseng Nutrition 0.000 claims description 2
- 230000008676 import Effects 0.000 claims description 2
- 238000012856 packing Methods 0.000 claims description 2
- 241000208340 Araliaceae Species 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 35
- 230000000694 effects Effects 0.000 abstract description 34
- 210000004369 blood Anatomy 0.000 abstract description 32
- 230000001717 pathogenic effect Effects 0.000 abstract description 14
- 235000009508 confectionery Nutrition 0.000 abstract description 12
- 230000001737 promoting effect Effects 0.000 abstract description 10
- 238000005728 strengthening Methods 0.000 abstract description 8
- 210000004027 cell Anatomy 0.000 abstract description 7
- 206010037660 Pyrexia Diseases 0.000 abstract description 6
- 239000003513 alkali Substances 0.000 abstract description 5
- 230000036528 appetite Effects 0.000 abstract description 5
- 235000019789 appetite Nutrition 0.000 abstract description 5
- 210000003743 erythrocyte Anatomy 0.000 abstract description 5
- 230000002401 inhibitory effect Effects 0.000 abstract description 5
- 102000001554 Hemoglobins Human genes 0.000 abstract description 4
- 108010054147 Hemoglobins Proteins 0.000 abstract description 4
- 235000000177 Indigofera tinctoria Nutrition 0.000 abstract description 4
- 240000005373 Panax quinquefolius Species 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 229940097275 indigo Drugs 0.000 abstract description 3
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 abstract description 3
- 244000283207 Indigofera tinctoria Species 0.000 abstract description 2
- 241000334154 Isatis tinctoria Species 0.000 abstract description 2
- 230000003915 cell function Effects 0.000 abstract description 2
- 230000003247 decreasing effect Effects 0.000 abstract description 2
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 230000012010 growth Effects 0.000 abstract description 2
- 239000003688 hormone derivative Substances 0.000 abstract description 2
- 210000000265 leukocyte Anatomy 0.000 abstract description 2
- 235000012054 meals Nutrition 0.000 abstract description 2
- 240000006432 Carica papaya Species 0.000 abstract 1
- 235000009467 Carica papaya Nutrition 0.000 abstract 1
- 235000017784 Mespilus germanica Nutrition 0.000 abstract 1
- 244000182216 Mimusops elengi Species 0.000 abstract 1
- 235000000560 Mimusops elengi Nutrition 0.000 abstract 1
- 241000972673 Phellodendron amurense Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 241000270666 Testudines Species 0.000 abstract 1
- 235000007837 Vangueria infausta Nutrition 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 230000003750 conditioning effect Effects 0.000 abstract 1
- 238000007596 consolidation process Methods 0.000 abstract 1
- 230000009707 neogenesis Effects 0.000 abstract 1
- 239000006187 pill Substances 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 25
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 21
- 239000000126 substance Substances 0.000 description 20
- 201000010099 disease Diseases 0.000 description 19
- 210000003734 kidney Anatomy 0.000 description 18
- 238000011160 research Methods 0.000 description 18
- 230000007812 deficiency Effects 0.000 description 15
- 230000000144 pharmacologic effect Effects 0.000 description 15
- 210000000952 spleen Anatomy 0.000 description 14
- 210000004072 lung Anatomy 0.000 description 13
- 208000002193 Pain Diseases 0.000 description 11
- 210000001124 body fluid Anatomy 0.000 description 11
- 239000010839 body fluid Substances 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- 230000036407 pain Effects 0.000 description 11
- CRDNMYFJWFXOCH-YPKPFQOOSA-N (3z)-3-(3-oxo-1h-indol-2-ylidene)-1h-indol-2-one Chemical compound N/1C2=CC=CC=C2C(=O)C\1=C1/C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-YPKPFQOOSA-N 0.000 description 10
- 239000002253 acid Substances 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- 208000004880 Polyuria Diseases 0.000 description 8
- 230000035619 diuresis Effects 0.000 description 8
- 210000002216 heart Anatomy 0.000 description 8
- 231100000614 poison Toxicity 0.000 description 7
- 206010010904 Convulsion Diseases 0.000 description 6
- 208000015220 Febrile disease Diseases 0.000 description 6
- 230000036461 convulsion Effects 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- CRDNMYFJWFXOCH-BUHFOSPRSA-N Couroupitine B Natural products N\1C2=CC=CC=C2C(=O)C/1=C1/C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-BUHFOSPRSA-N 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 5
- 210000000232 gallbladder Anatomy 0.000 description 5
- 210000003714 granulocyte Anatomy 0.000 description 5
- CRDNMYFJWFXOCH-UHFFFAOYSA-N isoindigotin Natural products N1C2=CC=CC=C2C(=O)C1=C1C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-UHFFFAOYSA-N 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 4
- 230000002607 hemopoietic effect Effects 0.000 description 4
- 210000002751 lymph Anatomy 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 4
- 230000000630 rising effect Effects 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 3
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 208000037319 Hepatitis infectious Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 208000033809 Suppuration Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 239000001654 beetroot red Substances 0.000 description 3
- 235000012677 beetroot red Nutrition 0.000 description 3
- 235000002185 betanin Nutrition 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 150000002338 glycosides Chemical class 0.000 description 3
- 208000014617 hemorrhoid Diseases 0.000 description 3
- 208000005252 hepatitis A Diseases 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 208000013403 hyperactivity Diseases 0.000 description 3
- 230000001077 hypotensive effect Effects 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 210000005087 mononuclear cell Anatomy 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 235000013599 spices Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 230000001502 supplementing effect Effects 0.000 description 3
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010010144 Completed suicide Diseases 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 239000010282 Emodin Substances 0.000 description 2
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 241001062009 Indigofera Species 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- MAYJEFRPIKEYBL-OASIGRBWSA-N Obacunone Chemical compound C=1([C@@H]2OC(=O)[C@H]3O[C@@]43[C@]3(C)C(=O)C[C@H]5C(C)(C)OC(=O)C=C[C@]5(C)[C@H]3CC[C@]42C)C=COC=1 MAYJEFRPIKEYBL-OASIGRBWSA-N 0.000 description 2
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 2
- 241000382362 Persicaria tinctoria Species 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- VQQVWGVXDIPORV-UHFFFAOYSA-N Tryptanthrine Chemical compound C1=CC=C2C(=O)N3C4=CC=CC=C4C(=O)C3=NC2=C1 VQQVWGVXDIPORV-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 150000008425 anthrones Chemical class 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000003613 bile acid Substances 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 238000010322 bone marrow transplantation Methods 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 2
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 238000009313 farming Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 210000003494 hepatocyte Anatomy 0.000 description 2
- 230000002443 hepatoprotective effect Effects 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- VSLDMVSILHVDSR-UHFFFAOYSA-N obacunone Natural products CC1(C)OC(=O)C=CC2(C)C1CC(=O)C3(C)C2CCC4(C)C(OC(=O)C5OC345)c6occc6 VSLDMVSILHVDSR-UHFFFAOYSA-N 0.000 description 2
- 230000001354 painful effect Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- -1 tepor Substances 0.000 description 2
- 235000019157 thiamine Nutrition 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 239000011721 thiamine Substances 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 1
- DKPMWHFRUGMUKF-UHFFFAOYSA-N (3alpha,5alpha,6alpha,7alpha)-3,6,7-Trihydroxycholan-24-oic acid Natural products OC1C(O)C2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 DKPMWHFRUGMUKF-UHFFFAOYSA-N 0.000 description 1
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- RUDATBOHQWOJDD-UHFFFAOYSA-N (3beta,5beta,7alpha)-3,7-Dihydroxycholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 RUDATBOHQWOJDD-UHFFFAOYSA-N 0.000 description 1
- JOYGXTIHTHBSOA-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-thiophen-2-ylprop-2-en-1-one Chemical compound C1=CC(Cl)=CC=C1C(=O)C=CC1=CC=CS1 JOYGXTIHTHBSOA-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010048946 Anal abscess Diseases 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 206010002942 Apathy Diseases 0.000 description 1
- 208000032467 Aplastic anaemia Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000228197 Aspergillus flavus Species 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- TYPSVDGIQAOBAD-DZGCQCFKSA-N Atractylone Chemical compound C([C@]1(C)C2)CCC(=C)[C@@H]1CC1=C2OC=C1C TYPSVDGIQAOBAD-DZGCQCFKSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- GWZYPXHJIZCRAJ-UHFFFAOYSA-N Biliverdin Natural products CC1=C(C=C)C(=C/C2=NC(=Cc3[nH]c(C=C/4NC(=O)C(=C4C)C=C)c(C)c3CCC(=O)O)C(=C2C)CCC(=O)O)NC1=O GWZYPXHJIZCRAJ-UHFFFAOYSA-N 0.000 description 1
- RCNSAJSGRJSBKK-NSQVQWHSSA-N Biliverdin IX Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(\C=C/2C(=C(C)C(=C/C=3C(=C(C=C)C(=O)N=3)C)/N\2)CCC(O)=O)N1 RCNSAJSGRJSBKK-NSQVQWHSSA-N 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 240000004528 Catalpa ovata Species 0.000 description 1
- 235000010005 Catalpa ovata Nutrition 0.000 description 1
- QIIDATRCGITYRZ-UHFFFAOYSA-N Catalpol Natural products OCC1OC(OC2OC=CC3C(O)C(=C(CO)C23)O)C(O)C(O)C1O QIIDATRCGITYRZ-UHFFFAOYSA-N 0.000 description 1
- 201000006082 Chickenpox Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- OMFXVFTZEKFJBZ-UHFFFAOYSA-N Corticosterone Natural products O=C1CCC2(C)C3C(O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 OMFXVFTZEKFJBZ-UHFFFAOYSA-N 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- GQEVCHQXWPWARL-UHFFFAOYSA-N Couroupitine A Natural products N1=CC=CC2=CC(=O)N3C4=CC=CC=C4C(=O)C3=C21 GQEVCHQXWPWARL-UHFFFAOYSA-N 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 240000002514 Cymbidium ensifolium Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 241000991587 Enterovirus C Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- DUAGQYUORDTXOR-GPQRQXLASA-N Gentiopicrin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](C=C)C2=CCOC(=O)C2=CO1 DUAGQYUORDTXOR-GPQRQXLASA-N 0.000 description 1
- DUAGQYUORDTXOR-WULZUDSJSA-N Gentiopicrin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@H]1[C@@H](C=C)C=2C(C(=O)OCC=2)=CO1 DUAGQYUORDTXOR-WULZUDSJSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010027906 Monocytosis Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
- 102000048850 Neoplasm Genes Human genes 0.000 description 1
- 108700019961 Neoplasm Genes Proteins 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010073261 Ovarian theca cell tumour Diseases 0.000 description 1
- PTPHDVKWAYIFRX-UHFFFAOYSA-N Palmatine Natural products C1C2=C(OC)C(OC)=CC=C2C=C2N1CCC1=C2C=C(OC)C(OC)=C1 PTPHDVKWAYIFRX-UHFFFAOYSA-N 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 208000037062 Polyps Diseases 0.000 description 1
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 1
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 1
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- PZZRDJXEMZMZFD-ODPGBAFUSA-N Reynoutrin Natural products O[C@H]1[C@H](O)[C@@H](O)CO[C@@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O PZZRDJXEMZMZFD-ODPGBAFUSA-N 0.000 description 1
- RLTYFLICIIZAKQ-UHFFFAOYSA-N Rhababerone Chemical group O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C=C(C)C(O)=C2 RLTYFLICIIZAKQ-UHFFFAOYSA-N 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 206010042220 Stress ulcer Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 206010046980 Varicella Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- TYPSVDGIQAOBAD-UHFFFAOYSA-N atractylone Natural products C1C2(C)CCCC(=C)C2CC2=C1OC=C2C TYPSVDGIQAOBAD-UHFFFAOYSA-N 0.000 description 1
- BDCDNTVZSILEOY-UXYNSRGZSA-N avicularin Chemical compound O[C@@H]1[C@@H](O)[C@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O BDCDNTVZSILEOY-UXYNSRGZSA-N 0.000 description 1
- QIARVOTYSDZZQL-UHFFFAOYSA-N avicularin Natural products OCC1OC(Oc2cc(O)c3C(=O)C(=C(Oc3c2)c4ccc(O)c(O)c4)O)C(O)C1O QIARVOTYSDZZQL-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003858 bile acid conjugate Substances 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- QBUVFDKTZJNUPP-UHFFFAOYSA-N biliverdin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(C=C2C(=C(C)C(C=C3C(=C(C=C)C(=O)N3)C)=N2)CCC(O)=O)N1 QBUVFDKTZJNUPP-UHFFFAOYSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- JGIATAMCQXIDNZ-UHFFFAOYSA-N calcium sulfide Chemical compound [Ca]=S JGIATAMCQXIDNZ-UHFFFAOYSA-N 0.000 description 1
- 239000001175 calcium sulphate Substances 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- LHDWRKICQLTVDL-PZYDOOQISA-N catalpol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2[C@@]3(CO)O[C@H]3[C@@H](O)[C@@H]2C=CO1 LHDWRKICQLTVDL-PZYDOOQISA-N 0.000 description 1
- UXSACQOOWZMGSE-UHFFFAOYSA-N catalposide Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(OC(=O)C=3C=CC(O)=CC=3)C2C=CO1 UXSACQOOWZMGSE-UHFFFAOYSA-N 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- RUDATBOHQWOJDD-BSWAIDMHSA-N chenodeoxycholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-BSWAIDMHSA-N 0.000 description 1
- 229960001091 chenodeoxycholic acid Drugs 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000001989 choleretic effect Effects 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- OMFXVFTZEKFJBZ-HJTSIMOOSA-N corticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OMFXVFTZEKFJBZ-HJTSIMOOSA-N 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
- 229960003964 deoxycholic acid Drugs 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 230000010437 erythropoiesis Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- DFNZYFAJQPLJFI-UHFFFAOYSA-N gentianine Chemical compound O=C1OCCC2=C1C=NC=C2C=C DFNZYFAJQPLJFI-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- ALRFYJWUVHBXLV-UHFFFAOYSA-N guaijaverin Natural products OC1COC(COC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O ALRFYJWUVHBXLV-UHFFFAOYSA-N 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- COHYTHOBJLSHDF-BUHFOSPRSA-N indigo dye Chemical compound N\1C2=CC=CC=C2C(=O)C/1=C1/C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-BUHFOSPRSA-N 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- YOBAEOGBNPPUQV-UHFFFAOYSA-N iron;trihydrate Chemical compound O.O.O.[Fe].[Fe] YOBAEOGBNPPUQV-UHFFFAOYSA-N 0.000 description 1
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000005976 liver dysfunction Effects 0.000 description 1
- 208000030208 low-grade fever Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- LHDWRKICQLTVDL-UHFFFAOYSA-N methyl iridoid glycoside Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(O)C2C=CO1 LHDWRKICQLTVDL-UHFFFAOYSA-N 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 208000025113 myeloid leukemia Diseases 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- QUCQEUCGKKTEBI-UHFFFAOYSA-N palmatine Chemical compound COC1=CC=C2C=C(C3=C(C=C(C(=C3)OC)OC)CC3)[N+]3=CC2=C1OC QUCQEUCGKKTEBI-UHFFFAOYSA-N 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 238000011170 pharmaceutical development Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- BDCDNTVZSILEOY-UHFFFAOYSA-N polystachoside Natural products OC1C(O)C(CO)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O BDCDNTVZSILEOY-UHFFFAOYSA-N 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 206010037833 rales Diseases 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 208000001644 thecoma Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 208000009421 viral pneumonia Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a Chinese medicine composition for treating acute and chronic granulocytic leukemia 1 and a preparation method thereof. 18 Chinese medicinal herbs including natural indigo, rehmannia root, isatis indigotica fort, turtle shell, papaya, Ningqi medlar, amur corktree bark, American ginseng, astragalus root, radix polygoni multiflori preparata and the like are compounded and prepared into oral capsules according to a proportion. The Chinese medicine composition is salty, sweet, pungent, amaroidal and cold and astrictive, has effects of clearing heat, detoxicating, tonifying Qi, nourishing blood, promoting appetite, relieving uneasiness, reducing a fever, strengthening body resistance to eliminate pathogenic factors, inhibiting growth of myelomonocytic granular cells and white blood cells, reversing sick cell functions to be normal, conditioning to balance a blood system, enhancing physical immunity, promoting neogenesis of red blood cells and hemoglobin and promoting rehabilitation, and has no toxic or side effects and a unique treatment effect on acute and chronic granulocytic leukemia. The Chinese medicine composition is orally taken three times a day with five pills each time by an adult after mixed with warm boiled water before meals; and for children, the dosage is slightly decreased according to the age or the quantitative dosage advised by a doctor. The Chinese medicine composition is taken for more than half a year until the international normal value of the blood system is reached and then taken for one month for consolidation preferably. During taking the Chinese medicine composition, following attentions are followed: patients are avoided eating sour, alkali, cholic, pickled, spiced, pungent, hot and high-protein foods; pregnant women are cautious to take the Chinese medicine composition; and the Chinese medicine composition is avoided being used together with Western synthetic hormone drugs.
Description
Treatment by Chinese herbs acute and chronic neutrophilic type leukemia 1 combination and preparation method thereof:
The present invention relates to leukemic Chinese medicine composition decoct of a kind of treatment acute and chronic neutrophilic type and the capsular method of preparation, belong to the field of Chinese medicines.
Leukemia is one of human important cause of the death, 1,300 ten thousand new cases are arranged global every year approximately, mortality rate is up to more than 95%, cause that various countries gaze at, China is one of district occurred frequently, (according to the director of the Red Cross Society of China, there are every year 4000000 leukaemics to wait for the bone marrow transplantation treatment approximately in China, Shenzhen Zong Ku has 2600 parts of skeletons, had only ten patients to match benefited (selecting from " health of masses newspaper " total the 657th phase) in 2 years, the bone marrow transplantation of doctor trained in Western medicine is difficult to find the pairing of adaptation and will spends several ten ten thousand RMB, and ordinary person can not bear, the total effects for the treatment of leukemia is ground less than 3 percent in the whole world, the poor several households of the ill doctor of one people, the whole world is ground treating leukemia and spent the more than one hundred billion huge fund every year, and is still blank on Drug therapy, the whole world has up to ten million people to be devitalized by leukemia every year, and primary disease is a human anxious difficult problem for the treatment of the merit gram.I think that the whole world grinds treating leukemia incorrect " understanding " and all explore in two big " mistaken ideas ", basic theorem is wrong in all things, things is " being difficult for " success just, doctor trained in Western medicine is ground and controlled is the hereditism, I think and am only shortcut from the zoobiotism developmental research of the traditional Chinese medical science, the traditional Chinese medical science is the biochemical peptide material with living matter " mediate reason " animal pathological changes, biochemical peptide material is the base substance of all things on earth life, therefrom pharmaceutical developments research shortcut is scientific, the traditional Chinese medical science has experienced vicissitudes in thousand, and what do not lean on is to reach a cure, and the characteristic advantage that lengthens one's life arranged, it is two fruits of producing effects of small investment high repayment that Chinese medicine is cured the disease, Chinese medicine is 21 century best to be human object of study of curing the disease, " World Science circle was once foretold: crack the dead password of cancer gene, final beat cancer must be the Chinese traditional Chinese medical science undoubtedly ".The whole world is all unsatisfactory to leukemic various method of treatment effects at present, and it is costly, therefore there is the anxious demand for the treatment of in people to the leukemic medicine of effective treatment, up to now also do not find the report of the relevant present composition, the present invention is through long-term clinical practice and related data, (and participating in the 3rd the intractable leukemia seminar in the whole nation that calendar year 2001 Chinese people liberation is sponsored), analysis and research pathogenesis and condition of illness from hundreds of routine medical records.1, different depth taste functions declines or imbalance are arranged before patient's disease, lack of appetite and aplastic anemia and immunologic function degression are arranged.2, just do not have immunologic function and hemopoietic function after the morbidity, mainly do not have appetite.3, blood system cells function mutation, it mainly is mononuclear cell, lymphocyte and granulocyte, multiple is three types, the mononuclear cell person of exceeding standard 103 examples from 108 routine leukemia, account for about 94.7%, wherein the substate type 51 routine monokaryon person of exceeding standard 49 examples account for about 96.2%, and lymph type 34 routine monokaryons 31 examples that exceed standard account for 90.6%, granulocyte type 23 examples, monokaryon 21 examples that exceed standard account for about 92.3%.It is phagocyte that primary disease is mainly the mixed mutually mutation of monokaryon, lymph, granulocyte, and engulfs erythrocyte, causes the pathological phenomenon of leukoblast rising red blood cell decreased.And low grade fever's difficulty occurs and the main feature that mixes phenomenon such as move back, mainly divide three types: 1, substate type.2, lymph type.3, granulocyte type, three types all have general character and non-general character, therefore, the classification treatment just can reach better effects in the treatment, avoid eighteen incompatible medicaments and nineteen medicaments of mutual restraint with Chinese medicine in the combination, medication is in conjunction with the comprehensive therapeutic alliance of the state of an illness, and medication will coordinate to reach the purpose that As the medicine took effect, the symptoms lessened mutually.
The present invention has found the leukemic interior oral compositions of treatment granulocyte type finally, thereby has finished the present invention through long-term clinical and medical record data and research repeatedly.
Another object of the present invention provides leukemic composition decoction of treatment by Chinese herbs acute and chronic neutrophilic type and the capsular method of preparation.
(1) Indigo Naturalis is selected in the present invention's combination for use, and property is salty, and little hardship is cold, goes into Liver Channel.Heat-clearing and toxic substances removing, blood cooling and ecchymoses removing is used for heat in blood and sends out speckle, and infantile convulsion is desired skin ulcer." property of medicine opinion " separates children's's infantile malnutrition with fever, becomes thin parasite killing.According to chemical analysis, contain indigo, indirubin, couroupitine A and a large amount of inorganic salts etc.According to pharmacological research, indirubin is to ehrlich carcinoma, multiple zoopery tumors such as watt Ke Shi cancer 256 have inhibitory action, can suppress the synthetic of DNA (deoxyribonucleic acid), the myelocytic leukemia cell is had destruction, and it is multiple normal that the chromosomal distortion of chronic myelocytic leukemia patient sick cell is descended, to Normocellular lymph hepatocyte, the synthetic unrestraint effect of the deoxidation nucleic acid of medullary cell has certain liver protection effect.According to clinical report, with Indigo Naturalis or indirubin treatment chronic myelocytic leukemia curative effect is preferably arranged, with indirubin treatment chronic myelocytic leukemia 314 examples, complete remission rate is 26.1%, total effective rate is 87.3%, effective with indirubin treatment acidophilia leukaemia increase disease, consumption 2-5 restrains powder or takes after mixing it with water and do not make decoct.
(2) the combination Radix Rehmanniae, property is sweet, and little hardship is cold, go into the heart, Liver and kidney warp, clearing away heat and cooling blood are gone into blood part, are used for damp and hot patient and seek part, disease is seen fever of the body, and is thirsty, the red tongue person of falling, YIN nourishing and the production of body fluid promoting, nourishing YIN to relieve dryness is arranged, and the merit of promoting the production of body fluid is used for the epidemic febrile disease later stage, consumption of body fluid by heat, thirsty, constipation, tongue falls and dried person, this product sweet can yin nourishing hemopoietic, be used for the cardiopalmus of deficiency of YIN-blood, regularly intermittent pulse person.Shennong's Herbal master folding falls exhausted wound, by arthralgia due to stagnation of blood, fills out bone marrow, and longue meat removes cold and heat and gathers, eliminating impediment, and clothes are made light of one's life by commiting suicide not old for a long time.Chemical analysis, contain B-sitosterol, catalpol, monosaccharide, aminoacid (as lysine, arginine) etc., according to pharmacological research: can suppress 17-hydroxy-11-dehydrocorticosterone catabolism in liver on the kidney, energy Fructus Citri tangerinae Hangzhoupro, contained Chinese catalpa dexamethasone is to the inhibitory action of interrenal system, can make plasma corticosterone remain on normal level, anti-radiation function is arranged, the platelet decline that the radiation rat is caused can make to go up to accelerate, the white mice cell decline that cyclophosphamide is caused has therapeutical effect, consumption 10-30 gram.
(3) compoboard Cymbidium ensifolium (L.) Sw. root: the property hardship, trembling with fear, go into the heart, kidney, lung meridian, heat-clearing and toxic substances removing, clearing away heat-fire, separate the pestilence poison, is the key medicine of clear excess-fire, and bitter cold is gone into blood part, the branch pyretic toxicity purifies the blood, be used for epidemic febrile disease and go into blood part, the kind shape heat that epidemic febrile disease is gone into blood part, the coma of separating, clearing throat, parotitis, infectious hepatitis etc., band shape herpes, chickenpox, flu influenza, viral pneumonias etc. are according to chemical analysis: contain Acanthaceous indigo, Song Lan, careless Folium Isatidis, polygonum tinctorium ait. etc. and all contain the blue or green glycoside of deciding.Clinical report is used for encephalitis b, infectious hepatitis, and monocytosis, the higher person of clinical practice mononuclear cell has unique therapeutic effect, consumption 20-30 gram.Heavy dose of 40-60 gram.
(4) combination Carapax Trionycis, property salty, be slightly cold, go into liver, kidney channel.The tonifying YIN YANG hyperactivity suppressing is used for hyperactivity of YANG due to deficiency of YIN, consumption of YIN caused by febrile disease, and the disease of stirring-up of pathogenic wind in the interior resulting from deficiency, hard masses softening and resolving, it is hard long-pending to be used for disease Shennong's Herbal Zhu Xin mass in the abdomen such as Gan Pi Zhong Da lumps in the chest and abdomen, and cold and heat remove the painful abdominal mass polyp, and erosion of the vulva hemorrhoid are disliked meat.Chemical analysis: contain animal glue, keratin, iodine matter, vitamin D etc., pharmacological research, this product has the effect that suppresses connective tissue proliferation and improve hemoglobin, consumption 20-30 gram.
(5) combination Fructus Chaenomelis: property acid, tepor, gas perfume (or spice), go into liver, spleen channel, acid, relaxing muscles and tendons and activating QI and blood in the collateral, wet perfume (or spice) dries, stomach function regulating removing dampness, the Shujin that can promote the production of body fluid, the gas perfume (or spice) stomach function regulating of being amusing." Mingyi Bielu " main arthralgia chiefly caused by damp pathogen pathogen, cholera is told down greatly, and convulsion is more than.According to chemical analysis, contain Saponin, organic acid, flavonoid, tannin etc., consumption 6-15 gram.
(6) combination NINGQI: property is sweet puts down, goes into liver, kidney, lung meridian.The YIN nourishing of enriching blood is good at tonifying liver blood, is usually used in the asthenia asthenia of essence and blood, and replenishing vital essence to improve eyesight is usually used in having a dizzy spell due to the asthenia of essence and blood, visual deterioration, diseases such as platycoria, can nourishing the liver and kidney lung benefiting the moon again." book on Chinese herbal medicine is focused " nourishing the essence and strengthening QI, prosperous and powerful vagina according to chemical analysis, contains betanin, carotene, thiamine, riboflavin, Yan acid, ascorbic acid etc.According to pharmacological research, experiment has the promotion immunologic function, strengthen the effect of resistance against diseases, the normal cell hemopoietic function there is facilitation, lipotropy is arranged, irritate the mice that stomach is poisoned carbon tetrachloride, the fatty intrahepatic deposition of slight inhibition is arranged with the lycium barbarum infusion, promote hepatocyte new life's effect, and can prevent the liver dysfunction that carbon tetrachloride causes.Consumption 5-10 gram.Heavy dose of 15-20 gram.
(7) combination Cortex Phellodendri: property hardship, cold, go into kidney, bladder, large intestine channel, eliminating fire and detoxication, heat clearing and damp drying is rushed down the kidney fire, and reducing the asthenic fever is used for the disease of the osteopyrexia and fever of kidney high Sheng of fire or hyperactivity of fire caused by deficiency of YIN.Accumulation of heat in the Shennong's Herbal master the five internal organs the intestines and stomach, jaundice, perianal abscess is rushed down profit, woman's whitish metrorrhagia, negative and positive phagedenoma.According to chemical analysis, contain lobule alkali, a small amount of palmatine, obacunone, Cortex Phellodendri lactone etc., the same Rhizoma Coptidis of this product; fungus is had inhibitory action, platelet is had protective effect, it is broken that it is difficult for, and diuresis is arranged; contained lobule alkali has multiple pharmacological effect, consumption 3-12 gram, heavy dose of available 15-20 gram.
(8) combination import ginseng (U.S. or Canada produce): property is sweet, and little hardship is trembled with fear into the heart, lung, stomach, kidney channel, the QI invigorating pathogenic fire reducing is used for asthenic fire punishment gold, YIN-deficiency of the lung and kidney, impairment of purifying function of the lung has the lung heat clearing pathogenic fire reducing, the effect of supplementing QI and nourishing YIN, promoting the production of body fluid to quench thirst, be used for the tired tired thirsty of cloudy two parts of calentura gas, the effect of supplementing QI for promoting the production of body fluid is arranged, be usually used in the acute and chronic calentura, the disease of the cloudy violent trauma of gas has the effect of supplementing QI to prevent collapse." Bencao Congxin " tonifying the lung pathogenic fire reducing, last body fluid falls tired tired, empty and the person of lighting a fire is suitable.According to chemical analysis, contain glycoside, be mainly the panaquilon and contain Saponin, a small amount of volatile oil, resin, starch and sugar.Consumption 3-6 gram, heavy dose of available 10 grams.
(9) the combination Radix Astragali: property is sweet, and tepor is gone into spleen, lung meridian, tonifying Qi and lifting yang is used for the disease that deficiency of spleen-QI descends, the spleen is the source of growth and development, and anorexia and loose stool then appears in the lung is concerned with QI of the whole body, deficiency of both the splenic and pulmonary QI, be used for Qi and blood deficiency, benefit is defended consolidating superficial resistance, promoting pus discharge and tissue regeneration strengthening, inducing diuresis to remove edema is used for diabetes Shennong's Herbal master's carbuncle of deficiency of vital energy body fluid deficiency and loses skin ulcer, evacuation of pus pain relieving, leprosy disease, five hemorrhoid scrofula, tonify deficiency, children's's all kinds of diseases and ailments.According to chemical analysis, contain choline, betanin, aminoacid, sucrose, Pu Tao Tang Chuo acid and micro-folic acid.According to pharmacological research, cardiotonic is arranged, can strengthen myocardial contraction, hypotensive effect is arranged, its mechanism is with directly expansion is relevant, diuresis is arranged, and the output of sodium, increase, and reduces urine protein and the effect of pathologic urine protein, the effect of human body immunity improving function is arranged, interferon system there is facilitation, hepatoprotective is arranged in addition, prevent the effect that reduce in the glycogen source.Consumption 10-15 gram, heavy dose of 20-50 gram.
(10) combination Radix Polygoni Multiflori Preparata: property is sweet, bitter, puckery, little wet, goes into liver, kidney channel.Invigorating the liver and kidney, benefiting essence-blood are taken a tonic or nourishing food to build up one's health Kidney-Yinly, are used for the early whitening of beard and hair of yang deficiency insufficiency of blood, vertigo and head dark, the weak person of soreness of the waist and knees, arresting seminal emission, energy reinforcing the kindey to control nocturnal emission, detoxifcation laxation, separate sore, functions of loosening bowel relieving constipation is enriched blood and should be used system to give birth to crow, loosening bowel to relieve constipation Radix Polygoni Multiflori, " Kaibao Bencao " controls scrofula, and the pain that disappears is swollen, treats women's head-ornaments wind skin ulcer, controls five hemorrhoid, only pained, replenishing QI and blood, black beard and hair, improving healthy complexion, obey long muscles and bones for a long time, beneficial marrow, it is not old to prolong life, and also controls all diseases of married woman's puerperal and leukorrhagia.According to chemical analysis, contain the anthrone class, main is chrysophanol, emodin, less important is rhababerone, starch, crude fat and lecithin etc.According to pharmacological research, the intestinal tube of promotion creeping effect is arranged, the merit of relieving constipation is arranged, strong mentation is arranged, there is the overslaugh cholesterol in liver, to reach sedimentary effect in the blood vessel, thus the atherosclerosis of slowing down effect is arranged, and the effect of rising blood glucose source is arranged.The clinical report tablet has obvious effect to reducing serum cholesterol, consumption 10-30 gram.
(11) the combination Radix Paeoniae Alba: property hardship, acid, be slightly cold, go into liver, spleen, warp, suppressing liver-YANG can be let out liver-fire, holds back the come-up yang-energy, the yin fluid astringing that nourishes blood, deficiency of YIN deficiency, deficiency of YIN-blood, anemia person, menoxenia etc., easing the affected liver to relieve pain, the breast that is used for transverse invasion of hyperactive liver-QI or incoordination between the liver and stomach is coerced epigastric pain, dysentery stomachache." society's farming book on Chinese herbal medicine warp " main pathogen stomachache is removed arthralgia due to stagnation of blood, broken hard amassing, and cold and heat, hernia purplish or white patches on the skin, pain relieving diuresis QI invigorating according to chemical analysis, contain paeoniflorin, paeonol, paeoniflorin, volatilization wet goods.According to pharmacological research, paeoniflorin has calmness, analgesia, antiinflammatory and alleviates the effect of smooth muscle spasm, the animal stress ulcer there is preventive effect, can expands the strong blood vessel of hat, Acute Myocardial Ischemia in Rats due to the antagonism pituitrin, can expand peripheral blood vessel for the dog intravenous injection, liver protection effect is arranged, and pair cell immunity and humoral immunization have certain facilitation, and Aspergillus flavus is have Detoxication, consumption 6-15 gram, heavy dose of 20-30 gram.
(12) combination gypsum: property is sweet, hot, cold, goes into lung, stomach warp.Clearing away heat-fire, relieving restlessness is quenched the thirst, and is used for damp and hot pain, and heat is at edema caused by disorder of QI, high fever, excessive thirst sweating, the arteries and veins flood, the excess-heat disease of red tongue with yellow fur has the merit of promoting the production of body fluid, the acrid in the mouth expelling pathogenic factors from the exterior that can loose is gone out, thus pathogenic heat that can lung heat clearing stomach warp, the key medicine of dividing excess-heat for the lung heat clearing gastric qi, to epidemic febrile disease, the pyretic toxicity dermexanthesis, but clearing away heat-fire again expelling pathogenic factors from the exterior go out and the pathogenic heat Shennong's Herbal master apoplexy cold and heat heart subinverse gas of clearing heat in QI system branch, the xerostomia scorching tongue, the hardness and fullness in the abdomen pain is by evil ghost, the galactopoiesis incised wound, according to chemical analysis, moisture sulfur calcium (CSO
4-2H
2O) sulfide and trace iron, magnesium etc.According to pharmacological research, this product is to suppress the hyperfunction of thermotaxic centre and the stronger refrigeration function of generation.Simultaneously the antiperspirant maincenter also is suppressed, thus analgesic and not diaphoresis, the fraud of no impairment of body fluid, some becomes soluble-salt, is absorbed into blood at small intestinal, and calcium can suppress nervimuscular irritability and play calm, the painful effect in town, can lower vascular permeability, consumption 10-30 gram, heavy dose of 60-100 gram.
(13) combination Herba Taxilli: property is sweet, bitter, flat, goes into liver, kidney channel.Tonifying liver and kidney and strengthening bones and muscles, the wind-damp dispelling pain relieving, nourishing blood and preventing abortion is used for deficiency of the liver and kindey, the essence and blood loss, a little less than the waist knee joint muscles and bones flaccidity, QI invigorating fetus nourishing, articular instability apathy, the solid feotus vitality of the kidney invigorating.Shennong's Herbal master lumbago, children's's stiffback, pain be swollen, antiabortive, fill skin sends out tooth, grows the man.According to chemical analysis , Han Quercetin and avicularin etc., Herba Taxilli element, leaf contains neat fruit acid, B-face cream alcohol, the meso alcohol stewed, flavone compound etc., according to pharmacological research, blood pressure lowering is arranged, suppress skeleton poliovirus and other enterovirus, effect Bai Guo Herba Visci such as diuresis have the heart tonifying hypotensive effect, and Hong Guo Herba Visci has the heart tonifying diuresis, consumption 10-30 gram.
(14) combination Haematitum: property hardship, cold, go into liver, pericardium, stomach, kidney, warp, suppressing the hyperactive liver and subsiding YANG, tranquillizing and allaying excitement, the important city sending down the abnormal ascending QI, cooling blood for hemostasis is used for excessive rising of liver-YANG, and dizzy order expands, tinnitus Xiao Epilepsy epilepsy, the Yi gas of adverse rising of stomach-QI, vomiting, singultus, hemorrhage etc. due to the heat in blood disease.Shennong's Herbal master tuberculosis, kills smart thing evil spirit at harmful wind handleless cup poison, abdomen poisoning pathogen, and the woman is red to irrigate.Chemical analysis, trioxygen-containingization two ferrum are mixed with foreign material such as being stained with soil, peptide, magnesium, aluminum, silicon, arsenic, according to pharmacological research, sedation are arranged, and can promote the new life of erythrocyte and hemoglobin, consumption 10-30 gram.
(15) combination Radix Gentianae: property hardship, cold, go into liver, gallbladder, urinary bladder channel.Liver heat removing gallbladder excess-fire, damp-heat in lower-JIAO, liver-fire causes conjunctival congestion and swelling pain, diseases such as deafness, otopyosis, scrotum swell and ache, jaundice, pudendal pruritus leucorrhea, eczema.Cold and heat, infantile convulsion pathogen between Shennong's Herbal master bone, continuous exhausted the wound, fixed five will are killed the handleless cup poison, obey Fructus Alpiniae Oxyphyllae for a long time and do not forget, and it is not old to make light of one's life by commiting suicide.According to chemical analysis, contain gentiopicrin, erythricine, Radix Gentianae pigment, Radix Gentianae sugar etc.According to pharmacological research, can promote gastric secretion, free acid is increased, can make stomachic at taking medicine before meal, antiinflammatory hepatoprotective choleretic effect is arranged, the phagocytic function of inflammatory cell there is facilitation.The diuresis hypotensive effect is arranged, and to record pus bacillus, Bacillus typhi and gold-coloured staphylococci etc. has certain inhibitory action, and the damp-heat type infectious hepatitis is had the transaminase lowering effect, consumption 3-10 gram, heavy dose of 20-30 gram.
(16) combination Fructus Jujubae: property is sweet, flat, matter is moistened many liquid, goes into spleen, stomach warp, air making-up and spleen enlivening, nourishing blood to tranquillize the mind, relaxes the property of medicine, and the effect of invigorating the spleen and replenishing QI is arranged, and is used for gas and does not transport, taste, weakness, anorexia and loose stool, blood deficiency, shallow complexion, palpitation and insomnia, protection healthy energy.Shennong's Herbal master trusted subordinate pathogen, regulating the spleen and stomach is supported spleen, helps 12 warps, flat gastric qi, logical nine orifices is mended weak breath, and few body fluid is not enough, frightened in the body, heaviness of limbs and hundred medicines.According to chemical analysis, contain protein, fat, saccharide, calcium, phosphorus, ferrum and vitamin A, B, C etc.According to pharmacological research, the effect of the liver protecting, muscle strength reinforcing and weight increase is arranged, the effect that reduces acute, chronic hepatitis, liver cirrhosis, patients serum's glutamate pyruvate transaminase is arranged, consumption 10-30 gram.
(17) combination Calculus Bovis: property, hardship, sweet, cool, gas is fragrant, goes into the heart, Liver Channel, eliminate phlegm for resuscitation; dispelling wind and relieving convulsion, heat-clearing and toxic substances removing is good at clearing away heart-fire and eliminating phlegm; be used for closing in the epidemic febrile disease expectorant heat coma proverb of pericardium, the disease expectorant of rale apoplexy is stopped up, conscience is hot or faint from fear tic and infantile convulsion etc.Laryngopharynx swelling and pain, " wishing farming book on Chinese herbal medicine warp " main frightened carbuncle cold and heat such as pain pyogenic infections from tumour or sore, intenseness of heat Kuang Chi removes the evil ghost that pursues.According to chemical analysis, contain bilirubin, biliverdin, free bile acid (as cholic acid, chenodeoxycholic acid etc.).Conjugated bile acid (as Calculus Bovis bile salt etc.) heart tonifying material; SMCS; vitamin D calcium, duck, zinc, copper, ferrum, phosphorus etc.; the artificial Calculus Bovis adds starch with cattle and sheep bile acid, hyocholic acid, cholesterol, bilirubin and inorganic salt (magnesium sulfate, ferrous sulfate, calcium phosphate) to be mixed and made into; pharmacological research, the contained deoxycholic acid of Calculus Bovis, sodium cholate etc. can suppress leukocyte and move.Calculus Bovis and artificial Calculus Bovis have facilitation to the bone marrow erythropoiesis.Consumption 0.2-0.5 gram.
(18) combination Rhizoma Atractylodis Macrocephalae: the property hardship, sweet, warm, go into spleen, kidney channel, air making-up and spleen enlivening, dampness diuretic, strengthening superficial resistance to stop perspiration, QI invigorating is antiabortive, key medicine for air making-up and spleen enlivening is used for deficiency-weakness of spleen-QI, weak disease, the phlegm retention edema that spleen insufficiency water is wet to stop gathering, oliguria etc., the exterior deficiency spontaneous perspiration has the merit of strengthening superficial resistance to stop perspiration.The dead flesh of Shennong's Herbal main air cold-damp numbness, convulsion, gallbladder, hidroschesis, heat extraction.According to chemical analysis.Contain volatile oil, be mainly atractylone and Rhizoma Atractylodis Macrocephalae lactone, AB also contains mcg vitamin A.According to pharmacological research, diuresis is arranged.Experimental results show that slight hypoglycemic activity to suppressing renal tubules electrolyte and the re-absorbed result of water, consumption 6-15 gram.
The present invention selects Indigo Naturalis for use through the combination of helping each other; the Radix Rehmanniae; Radix Isatidis; Carapax Trionycis; Fructus Chaenomelis; NINGQI; Cortex Phellodendri; Radix Panacis Quinquefolii; the Radix Astragali; Radix Polygoni Multiflori Preparata; the Radix Paeoniae Alba; Gypsum Fibrosum; Herba Taxilli; Haematitum; Radix Gentianae; Fructus Jujubae; Calculus Bovis; Rhizoma Atractylodis Macrocephalae combination becomes second nature salty; flat; Gan Xin; be slightly cold; bitter; puckery; it is liquor-saturated that chemical analysis contains B-paddy steroid; polysaccharide; aminoacid; keratin; carotene; thiamine; riboflavin; Yan acid; ascorbic acid; lobule alkali; obacunone; the panaquilon; Saponin; the Isatis indigotica Fort (Indigofera tinctoria L, Baphicanthus cusia (nees) Brem. Polygonum tinctorium Ait) glycoside; choline; betanin; the anthrone class; chrysophanol; emodin; paeoniflorin; H 2 O calcium sulphate Quercetin; iron sesquioxide; gentiin alkaline color element; protein; the red verdazulene of gallbladder; multivitamin etc.; said medicine can be coordinated mutually; without any side effects; heat-clearing and toxic substances removing is arranged; the heat of dispelling is brought down a fever; benefiting qi and nourishing blood; appetite promoting and the spleen strengthening; strengthen appetite; suppress monokaryon and increasement of leucocyte; it is normal to reverse the disease cell function; promote hemoglobin and erythrocyte new life; enhancing human body immunity and hemopoietic function; there is strengthening vital QI to eliminate pathogenic factors to promote the effect of rehabilitation, acute and chronic substate type leukemia is had unique therapeutic effect.
2, decoct method of the present invention; its feature is with mashed in Carapax Trionycis pulverizing, Haematitum, the Gypsum Fibrosum; three flavor medicines add water and were decocted first 30 minutes; after 12 flavor Chinese medicines except that Indigo Naturalis, Calculus Bovis, Radix Panacis Quinquefolii such as the Radix Rehmanniae, Radix Isatidis are pulverized coarser powder and be soaked in water 5 minutes with the three flavor medicines that are decocted first, 25 minutes taking liquid 220 grams that are fried boiling; 20 minutes taking liquid 180 grams are boiled in water; 15 minutes taking liquid 150 grams again are boiled in water; three liquid 550 gram medicinal liquids of boiling medicine were fried in shallow oil the Radix Panacis Quinquefolii fragment 10 minutes; taking liquid 500 grams; divide three bovine calculus powders of taking after mixing it with water, above-mentioned is adult's daily dose.Annotate: the diet acid of taking medicine, alkali, gallbladder, salt down, halogen, suffering, peppery property and high protein food, avoid with Western medicine synthetic hormone medicine and use with.
3, capsule preparation method thereof: its feature 500 after with 2 fried Radix Panacis Quinquefoliis gram medical filtrations concentrate, and drying obtains dry extract and Calculus Bovis mixings porphyrize and spares under the 45-50 degree, and is standby in 15 capsules of packing into.
Claims (3)
1. treatment by Chinese herbs acute and chronic neutrophilic type leukemia 1 combination and preparation method thereof, it is made up of following routine bulk drugs proportioning:
Indigo Naturalis 4 grams, the Radix Rehmanniae 25 grams, Radix Isatidis 3 grams, Carapax Trionycis 30 grams, Fructus Chaenomelis 15 grams, NINGQI 15 grams, Cortex Phellodendri 15 grams, import ginseng 8 grams, the Radix Astragali 30 grams, Radix Polygoni Multiflori Preparata 30 grams, the Radix Paeoniae Alba 20 grams, Gypsum Fibrosum 30 grams, Herba Taxilli 30 grams, Haematitum 30 grams, Radix Gentianae 20 grams, Fructus Jujubae 20 grams, Calculus Bovis 0.5 gram, the Rhizoma Atractylodis Macrocephalae 12 grams.
2. the decocting method of the described compositions of claim 1; its feature is with mashed in Carapax Trionycis, pulverizing Gypsum Fibrosum, the Haematitum; three flavor medicines add water and were fried boiling earlier 30 minutes; after pulverizing coarser powder and be soaked in water 5 minutes with 12 flavor Chinese medicines except that Indigo Naturalis, Calculus Bovis, Radix Panacis Quinquefolii again; three flavor medicines restrain with the 25 minutes taking liquids 220 that are fried boiling with being decocted first; 20 minutes taking liquid 180 grams are boiled in water; be boiled in water again 15 minutes; taking liquid 150 grams; with medicinal liquid 550 grams of being fried in shallow oil for three times 10 minutes taking liquid 500 grams of Radix Panacis Quinquefolii fragment that are fried boiling; divide three take after mixing it with water Indigo Naturalis and bovine calculus powders, above-mentioned is adult's daily dose.
3. prepare the capsule method: claim 2 is described, the 500 gram medical filtrations that its feature is fried in shallow oil compositions, and drying obtains dry cream under the 45-50 degree, and is with dry cream and bovine calculus powder porphyrize, standby in 15 capsules of packing into.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011100426903A CN102091181A (en) | 2011-02-13 | 2011-02-13 | Chinese medicinal composition for treating acute and chronic granulocytic leukemia 1 and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011100426903A CN102091181A (en) | 2011-02-13 | 2011-02-13 | Chinese medicinal composition for treating acute and chronic granulocytic leukemia 1 and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102091181A true CN102091181A (en) | 2011-06-15 |
Family
ID=44124559
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011100426903A Pending CN102091181A (en) | 2011-02-13 | 2011-02-13 | Chinese medicinal composition for treating acute and chronic granulocytic leukemia 1 and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102091181A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103860660A (en) * | 2012-12-14 | 2014-06-18 | 陕西郝其军制药股份有限公司 | Medicament for treating acute and chronic leukemia and preparation method thereof |
CN105362692A (en) * | 2015-12-02 | 2016-03-02 | 钊桂英 | Preparation for treating acute leukemia and preparation method |
-
2011
- 2011-02-13 CN CN2011100426903A patent/CN102091181A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103860660A (en) * | 2012-12-14 | 2014-06-18 | 陕西郝其军制药股份有限公司 | Medicament for treating acute and chronic leukemia and preparation method thereof |
CN105362692A (en) * | 2015-12-02 | 2016-03-02 | 钊桂英 | Preparation for treating acute leukemia and preparation method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105749179A (en) | Traditional Chinese medicine composition for treating metabolic syndrome | |
CN102512615B (en) | Traditional Chinese medicinal composition used for cancer recovery stage | |
CN105688159A (en) | Method for preparing traditional Chinese medicine composition for treating solar dermatitis | |
CN102772737B (en) | Traditional Chinese medicine composition for treating liver cirrhosis and fibrosis and preparation method thereof | |
CN101716318B (en) | Traditional Chinese medicine preparation for treating tumor of digestive system | |
CN104940740A (en) | Traditional Chinese medicine composition for treating polycystic ovarian syndrome and preparation method thereof | |
CN103735775A (en) | Traditional Chinese medicine composition for treating iron deficiency anemia | |
CN101095923B (en) | Chinese traditional medicine for treating ectopic pregnancy | |
CN1109554C (en) | Medicine for treating allergic purpura | |
CN102526498A (en) | Chinese medicine for eliminating toxic and side effects after nasopharyngeal carcinoma radiotherapy and preparation method and administration way thereof | |
CN104524335A (en) | Pill for conditioning female endocrine disorders and preparation method of pill | |
CN101554456A (en) | Traditional Chinese medicine for treating cancer | |
CN104857455A (en) | Traditional Chinese medicine preparation for chronic interstitial nephropathy and preparation method thereof | |
CN104043058A (en) | Traditional Chinese medicinal preparation for treating kidney deficiency type lumbar disc herniation and preparation method thereof | |
CN102091181A (en) | Chinese medicinal composition for treating acute and chronic granulocytic leukemia 1 and preparation method thereof | |
CN104083728A (en) | Processing method of anticancer and tumor eliminating concentrated pill | |
CN104042981A (en) | Medicament for treating postnatal constipation and preparation method thereof | |
CN102085274A (en) | Traditional Chinese medicine composition for treating acute, chronic and subacute leukemia and preparation method thereof | |
CN104432386B (en) | Sangjisheng oral liquid for preventing soreness of waist and knees and weakness of muscles and bones and preparation method thereof | |
CN102091254B (en) | Traditional Chinese medicine composition for relieving swelling after cosmetic surgery and preparation method thereof | |
CN105435131A (en) | Traditional Chinese medicine composition for treating chronic heart failure and preparation method thereof | |
CN105106634A (en) | Traditional Chinese medicine preparation for treating acute appendicitis and application thereof | |
CN104888042A (en) | Chinese herbal preparation used for postpartum lochiorrhea and preparation method of Chinese herbal preparation | |
CN102579683A (en) | Chinese medicinal composition for treating acute and chronic lymphoid leukemia and development method thereof | |
CN104435962A (en) | Pharmaceutical composition for treating dyspeptic diarrhea of piglets and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110615 |